INSULIN DEFICIENCY AMONG NEWLY DIAGNOSED TYPE 2 DIABETICS

Authors

  • Tahira Naseem
  • Riffat Yasmin
  • Naeema Afzal
  • Ambreen Farrukh
  • Rubina Faisal Paul
  • Mukhtiar Hassan

Abstract

Background: Any patient above the age of 40 years, coming with the symptoms of diabetes islabelled as type 2 diabetic. If insulin levels are included in the protocol for initial investigations ofdiabetic patients, they can be differentiated as having insulin deficiency or insulin resistance. Theycan thus be treated accordingly. This study was conducted to see the prevalence of insulinresistance and insulin deficiency in newly diagnosed type 2 diabetics. Methods: This study wasconducted on 75 newly diagnosed diabetic subjects, and 75 control subjects for comparison.Fasting serum insulin was assayed by ELISA and HOMA-IR index was calculated. The diabeticsubjects with fasting hyperglycaemia and serum insulin level below 20 µIU/ml and HOMA-IRindex below 3.5 were grouped as insulin deficient (Group-A), and the diabetic subjects withfasting insulin level above 20 µIU/ml and HOMA-IR index above 3.5 were grouped as insulinresistant (Group-B). Results: Twenty-eight percent subjects were found to have insulin levelbelow 20 µIU/ml while 72% subjects had insulin resistance. When gender was taken intoconsideration, it was seen that 18.7% males had fasting insulin level of 6.98±0.737 µIU/ml and9.3% females had fasting insulin level of 5.21±0.885 µIU/ml while 32% males and 40% femaleshad insulin resistance. The mean age of male subjects with insulin resistance was significantlyhigher compared to the male subjects with insulin deficiency. Mean weight and body mass indexof the male and female subjects having insulin resistance was significantly higher than theirrespective control groups and also higher than the subjects with insulin deficiency. Pearsoncoefficient of correlation was calculated for fasting serum insulin level with age and BMI. Asignificant positive correlation was observed between fasting serum insulin and age of femaleswith insulin resistance. Conclusion: A considerable number of persons who develop diabetes after40 years of age but are not insulin resistant. Twenty-eight percent subjects have relative insulindeficiency, and 72% subjects have insulin resistance.Keywords: Type 2 diabetics, insulin deficiency, BMI

References

Atkinson MA, Maclaren NK. The pathogenesis of insulin

dependent diabetes. N Engl J Med 1994;331:1428–36.

Baekkeskov S, Neilson JH, Marner B, Bilde T, Ludsigsson J,

Lernmark A. Autoantibodies in newly diagnosed diabetic

children with immunoprecipitate human pancreatic islet cell

protein. Nature 1998;298:167–9.

Zimmet PZ, Tuomi T, Mackay R, Rowley MJ, Knowels W,

Cohen M, et al. Latent autoimmune diabetes mellitus in adults

(LADA): the role of antibodies to glutamic acid decarboxylase in

diagnosis and prediction of insulin dependency. Diabet Med

;11:299–303.

Banerji M, Lebovitz H. Insulin sensitive and insulin resistant

variants in IDDM. Diabetes 1989;38:784–92.

Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowels W,

Mackay IR. Antibodies to GAD reveal latent autoimmune DM in

adults with a non-insulin dependent onset of disease. Diabetes

;42:359–62.

Palmer JP, Hirsch IB. What’s in a name: Latent autoimmune

diabetes of adults, type 1.5, adult onset and type 1 diabetes.

Diabetes Care 2003;26:536–8.

Nabhan F, Emanuele MA, Emanuele N. Latent autoimmune

diabetes of adulthood. Unique features that distinguish it from

type 1 and 2. Postgraduate Medicine 2005;117:12–7.

Pietropaolo M, Barinas Mitchell E, Pietropaolo SL, Kuller LH,

Trucco M. Evidence of islet cell autoimmunity in elderly patients

with type 2 diabetes. Diabetes 2000;49:32–38.

Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett

JA, et al. Receptor and postreceptor defects contribute to the

insulin resistance in non-insulin dependent diabetes mellitus. J

Clin Invest 1981;68:957–9.

Butkeiwicz EK, Leibson C, O’Brien PC, Palumbo P, Rizza

RA. Insulin therapy for diabetic ketoacidosis. Bolus insulin

injection versus continuous insulin infusion. Diabetes Care

;18:1187–90.

J Ayub Med Coll Abbottabad 2012;24(2)

http://www.ayubmed.edu.pk/JAMC/24-2/Tahira.pdf

MacDonald MJ, Gapinski JP. A rapid ELISA for measuring

insulin in a large number of research samples. Metabolism

;38(5):450-2

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher

DF, Turner RC. Homeostasis model assessment: insulin

resistance and beta cell function from fasting plasma glucose and

insulin concentrations in man. Diabetologia 1985;28:412–9.

Asacaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R.

Diagnosing insulin resistance by simple quantitative methods in

subjects with normal glucose metabolism. Diabetes Care

;26:3320–5.

Carlsson A, Sundkvist G, Groop L, Tuomi T. Insulin and

Glucagon secretion in patients with slowly progressing

autoimmune diabetes (LADA). J Clin Endocrinol Metab

;85:76–80.

Jasem MA, Al-Ubaidi AA, Admon A, Zwaer KN. Prevalence of

LADA among clinically diagnosed type 2 diabetic patients. Med

J Islamic World Acad Sci 2010;18(2):49–54.

Pozzilli P, Dimario U. Autoimmune diabetes not requiring

insulin at diagnosis —definition, characterization and potential

prevention. Diabetes Care 2001;24:1460–7.

Gerich JE. Addressing the insulin secretion defect: a logical first

line approach. Metabolism 2000;49:12–6.

Caceres M, Teran CG, Rodriguez S, Medina M. Prevalence of

insulin resistance and its association with metabolic syndrome

criteria among Boivian children and adolescents with obesity.

BMC Paediatr 2008;8:31. doi: 10.1186/1471-2431-8-31.

Weber P, Ambrosova P, Canov P, Weberova D, Kulkilnek P,

Meluzinova H, et al. GAD antibodiesin T1D and LADA relation

to age, BMI, c-peptide, IA-2 and HLA-DRB103 and DRB 104

alleles. Adv Gerontol 2011;24(2):312–8.

Das S, Bhoi SK, Baliarsinha AK, Baig MA. Autoimmunity,

insulin resistance and cell function in subjects with low body

weight, type 2 diabetes mellitus. Metab Synd Relat Disord

;5(2):136–41.

Chen C, Tsai ST, Chou P. Correlation of fasting serum calcium

peptide and insulin with markers of metabolic syndrome in a

homogenous Chinese population with normal glucose tolerance.

Int J Cardiol 1999;68(2):179–86.

Gupta S, Kapse A. Lipid profile pattern in diabetics from central

India: Int J Diab Dev Countires 2001;21:138–45.

Unnikrishnam AG, Singh SK, Sanjeen CB. Prevalence of GAD

antibodies in lean subjects with type 2 diabetes. Ann NY Acad

Sci 2004;1037:118–21.

Nasution IR, Setiati S, Trisnohadi HB, Oemardi M. Insulin

resistance and metabolic syndrome in elderly women living in

nursing homes. Acta Med Indones 2006;38(1):17–22.

Fawwad A, Qasim R, Hydrie MIZ, Basit A, Miyan Z, Gul A.

Correlation of fasting insulin resistance indices with clinical

parameters of metabolic syndrome in type 2 diabetic subjects.

Pak J Med Sci 2006;22:433–7.

Bano KA, Begum M, Hussain R. Fasting blood levels of insulin

in non-obese and non-diabetic patients with essential

hypertension. Pak J Med Res 2004;43(1):5–7.

Yatsuya H, Tamakoshi K, Yoshida T, Hori Y, Zhang H,

Ishikawa M, et al. Association between weight fluctuation and

fasting insulin concentration in Japanese men. Int J Obes Relat

Metab Disord 2003;27:483–7.

Hettihewa LM, Dharmasiri LP, Ariyaratne CD, Jayasinghe SS,

Weerarathna TP, Kotapola IG. Significant correlation between

BMI/BW with insulin resistance by McAuley, HOMA and

QUICKI indices after 3 months of pioglitazone in diabetic

population. Int J Diab Dev Ctries 2007;27(3):87–92.

Downloads

Published

2012-06-01